9 Best Small-Cap Growth Stocks to Invest In Now
On June 30, CNBC released a research report noting that the US small-cap stocks are having the best first half since 1991.
Compass Therapeutics Inc. (CMPX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 17,990,782 | $39,399,813 | +8% | 1.79% |
| 2. | OrbiMed Advisors Samuel Isaly | 15,219,994 | $33,331,787 | 0.62% | |
| 3. | Suvretta Capital Management Aaron Cowen | 14,101,159 | $30,881,538 | -2% | 0.56% |
| 4. | Enavate Sciences James Boylan | 7,788,150 | $17,056,049 | 4.94% | |
| 5. | Vivo Capital Albert Cha And Frank Kung | 7,757,060 | $16,987,961 | -19% | 1.55% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.89 | 15,000 | $28,350.00 | 397,500 | 2026-04-29 | Filing | |
| $1.89 | 25,000 | $47,250.00 | 196,000 | 2026-04-29 | Filing | |
| $2.11 | 10,000 | $21,100.00 | 6,480,825 | 2025-05-27 | Filing | |
| $1.54 | 20,000 | $30,800.00 | 21,000 | 2025-04-07 | Filing | |
| $1.42 | 20,000 | $28,400.00 | 320,000 | 2025-04-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $4.36 | 2 | $8.72 | 1,060,414 | 2022-11-25 | Filing | |
| $4.30 | 9,569 | $41,146.70 | 1,060,416 | 2022-11-23 | Filing | |
| $4.19 | 14,929 | $62,552.51 | 1,069,985 | 2022-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,281,781 | $24,707,100 | 0% | |
| 2. | 9,953,653 | $21,798,500 | 0% | |
| 3. | 6,118,782 | $13,400,133 | 0% | |
| 4. | 3,815,189 | $8,357,450 | 0% | |
| 5. | 3,771,032 | $8,258,560 | 0% |
News See All
10 Small Cap Stocks with Potential to Rise 1000 Percent
Small-cap stocks have returned to the market’s risk conversation in 2026.
10 Best NASDAQ Stocks Under $5 to Buy Right Now
On April 28, Gabelli's John Belton joined 'Closing Bell Overtime' on CNBC to discuss how market expectations and overall investor sentiment have improved recently.
10 Best Day Trading Penny Stocks to Buy
Day trading penny stocks is not a normal buy-and-hold setup.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended period of market uncertainty in the prior year, noting that market attention ...
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory
We came across a bullish thesis on Compass Therapeutics, Inc. on r/stocks by Cute_Confidence6033. In this article, we will summarize the bulls’ thesis on CMPX.
Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment
On December 3, 2025, Compass Therapeutics, Inc. (NASDAQ:CMPX) saw Canaccord analyst John Newman initiate coverage of the stock with a “Buy” rating and a $10 price target.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement
On November 10, 2025, H.C. Wainwright’s Joseph Pantginis reiterated a “Buy” rating on Compass Therapeutics, Inc. (NASDAQ:CMPX) with a $24 price target.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Hedge Fund Resource Center